Page last updated: 2024-08-17

medroxyprogesterone acetate and Herpes Simplex Virus Infection

medroxyprogesterone acetate has been researched along with Herpes Simplex Virus Infection in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Baeten, JM; Beesham, I; Beksinka, M; Bukusi, E; Deese, J; Donnell, D; Edward, V; Heffron, R; Kourtis, AP; Morrison, C; Mugo, NR; Philip, NM; Rees, H; Scoville, CW; Stalter, RM	1
Cardozo-Ojeda, EF; Czartoski, J; Davé, VA; Erickson, J; Koehne, A; Lund, JM; Mair, F; Oberle, S; Potchen, N; Prlic, M; Schiffer, JT; Soerens, A; Teague, C; Woodward-Davis, AS; Zehn, D	1
Chappell, CA; Dezzutti, CS; Hillier, SL; Isaacs, CE; Meyn, LA; Moncla, BJ; Uranker, K; Xu, W	1
Brown, JM; Celentano, DD; Chipato, T; Cornelisse, P; Luoto, J; Mmiro, F; Morrison, CS; Mugerwa, R; Padian, N; Richardson, BA; Rugpao, S; Salata, RA	1

Trials

1 trial(s) available for medroxyprogesterone acetate and Herpes Simplex Virus Infection

Article	Year
Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-10, Volume: 75, Issue:4 Topics: Contraception; Contraceptive Agents, Female; Female; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Male; Medroxyprogesterone Acetate	2022

Article

Year

Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-10, Volume: 75, Issue:4

Topics: Contraception; Contraceptive Agents, Female; Female; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Male; Medroxyprogesterone Acetate

2022

Other Studies

3 other study(ies) available for medroxyprogesterone acetate and Herpes Simplex Virus Infection

Article	Year
Cervicovaginal Tissue Residence Confers a Distinct Differentiation Program upon Memory CD8 T Cells. Journal of immunology (Baltimore, Md. : 1950), 2021, 06-15, Volume: 206, Issue:12 Topics: Adult; Animals; CD8-Positive T-Lymphocytes; Cell Differentiation; Cervix Uteri; Female; Herpes Simplex; Herpesvirus 2, Human; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Vagina; Young Adult	2021
The effect of menopause on the innate antiviral activity of cervicovaginal lavage. American journal of obstetrics and gynecology, 2015, Volume: 213, Issue:2 Topics: Adult; Cervix Uteri; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Immunity, Innate; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Postmenopause; Premenopause; Vagina; Vaginal Douching; Viral Plaque Assay; Young Adult	2015
Hormonal contraception and the risk of HIV acquisition. AIDS (London, England), 2007, Jan-02, Volume: 21, Issue:1 Topics: Adult; Confidence Intervals; Contraception Behavior; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Disease Transmission, Infectious; Female; Herpes Simplex; Herpesvirus 2, Human; HIV; HIV Infections; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk; Thailand; Uganda; Zimbabwe	2007